Resource Type: Blog

Recently, one of the early adopters of the Digital Spatial Profiling (DSP) technology, Michael Davies, MD, PhD, the Deputy Chairman and Associate Professor in the Department of Melanoma Medical Oncology…

Oleg Butovsky, Ph.D., is an Assistant Professor of Neurology at Harvard Medical School. His laboratory at the Center of Neurologic Diseases in Brigham & Women's Hospital focuses on the basic…

The Neuropathology and Neuroinflammation panels are the newest addition to NanoString’s curated gene expression content poised to accelerate the pace of discovery in Alzheimer’s Disease (AD), Parkinson’s Disease, Huntington’s Disease…

Recently we had a conversation with key members of the scientific leadership team at NanoString. Joe Beechem, the Senior VP of Research & Development, and Alessandra Cesano, Chief Medical Officer,…

Interested in performing comprehensive multiplex gene expression analysis covering six fundamental themes of neurodegeneration: neurotransmission, neuron-glia interaction, neuroplasticity, cell structure integrity, neuroinflammation and metabolism? Wondering how you can narrow down these complex…

It’s been an exciting and productive annual meeting for the Society for Immunotherapy of Cancer (SITC) 2017, full of ground-breaking science to share when back in the lab. For those…

Your data doesn’t fit in a box Gone are the days of assay-specific data analysis. nSolver 4.0 is analyte focused and less assay restricted. This means that any combination of…

We love that you’re here. Here’s why you’re going to love it, too: Fun-size articles on nSolver & Advanced Analysis. In between scientific papers, grant applications, and your other lengthy…

Immune checkpoint inhibitors (ICI) have emerged as powerful tools against cancer but in some cases have caused inflammation of organ systems that contributed to morbidity or mortality in patients. The…

Part one of this four-part series looked at how host, tumor, and environmental factors shape tumor-immune system interactions. Part two further examined the role of the host, and in this…

Part one of this four-part series looked at how host, tumor, and environmental factors shape tumor-immune system interactions. In the next few blogs, we will consider how each of these…

President Jimmy Carter announced this spring that he no longer needed treatments for the metastatic melanoma found in his brain–after treatment with pembrolizumab (Keytruda, Merck), his physicians could no longer…